33 min listen
Drug Prices: A Dysfunctional Market Limits Patient Access
FromI AM BIO
ratings:
Length:
26 minutes
Released:
May 17, 2022
Format:
Podcast episode
Description
A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.Guests:Dan Durham, Senior Health Policy Advisor, Biotechnology Innovation OrganizationAnna Hyde, Vice President, Advocacy and Access, Arthritis FoundationDr. Vinay Rathi, Resident Physician, Otolaryngology, Massachusetts Eye and Ear and Mass General Brigham
Released:
May 17, 2022
Format:
Podcast episode
Titles in the series (100)
Vaccines are a Virtue: As biotech researchers work around the clock on a covid vaccine, ill-informed, anti-science anti-vaxxers must be denounced and excoriated in the public square. BIO’s head of infectious disease policy Phyllis Arthur administers a vital dose of vaccine education, because none of us is safe until we all are. Hosted by Jim Greenwood. by I AM BIO